Cancer HealthCast: This AI Tool Could Predict a Patient's Response to Immunotherapy

GovCIO Media & Research Podcasts

English - June 24, 2024 16:27 - 36 minutes - 27.1 MB - ★★★★★ - 14 ratings
Technology Government leadership technology artificial augmented cyber cybersecurity emerging government intelligence news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: HealthCast: How Health Equity By Design, AI Improves Health Care

Next Episode: TechNet Cyber: Developing the Cyber Workforce to Secure the DODIN

Artificial Intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.

Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).

Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.